Legal Representation
Attorney
Michelle D. Kahn
USPTO Deadlines
Application History
23 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 25, 2011 | MAB3 | O | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
Apr 14, 2011 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
Apr 14, 2011 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
Feb 28, 2011 | EXFB | T | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | Loading... |
Dec 10, 2010 | CNCF | S | ACTION CONTINUING FINAL - COMPLETED | Loading... |
Dec 10, 2010 | RECD | O | ACTION DENYING REQ FOR RECON MAILED | Loading... |
Nov 19, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
Nov 19, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 19, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 3, 2010 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
Nov 3, 2010 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Nov 3, 2010 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
Nov 3, 2010 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
May 3, 2010 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
May 1, 2010 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Mar 23, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 22, 2010 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 22, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 23, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 23, 2009 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Sep 16, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 22, 2009 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 20, 2009 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting public and professional interest in and awareness of the prevalence of prostate cancer; promoting public awareness of the need for prevention, early detection and treatment of prostate cancer
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"AWARENESS"